Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers

Journal of Molecular Neuroscience

Volumn 26, Issue 2-3, 2005, Pages 177-184

  Genedani, Susanna ^a   Guidolin, Diego ^a   Leo, Giuseppina ^a   Filaferro, Monica ^a   Torvinen, Maria ^b   Woods, Amina S ^c   Fuxe, Kjell ^b   Ferré, Sergi ^c   Agnati, Luigi F ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Adenosine A2A receptor; Caveolin 1; Dopamine D2 receptor; Heteromers; Internalization

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; CAVEOLIN 1; DIMER; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL CELL; CELLULAR DISTRIBUTION; CHO CELL; COMPUTER ANALYSIS; CONFERENCE PAPER; GENETIC TRANSFECTION; IMAGE ANALYSIS; INTERNALIZATION; LASER; MOLECULAR CLONING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION;

ANIMALS; CAVEOLIN 1; CAVEOLINS; CHO CELLS; CRICETINAE; DIMERIZATION; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RECOMBINANT PROTEINS; TRANSFECTION;

CRICETULUS GRISEUS;

EID: 25844479866     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:26:2-3:177     Document Type: Conference Paper

References (39)

1. Agnati L. F., Ferré S., Lluis C., Franco R., and Fuxe K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550.
2. Anderson R. G. (1998) The caveolae membrane system. Annu. Rev. Biochem. 67, 199-225.
3. Armstrong D. and Strange P. G. (2001) Dopamine D2 receptor dimer formation: evidence from ligand binding. J. Biol. Chem. 276, 22621-22629.
4. Bara-Jimenez W., Sherzai A., Dimitrova T., Favit A., Bibbiani F., Gillespie M., et al. (2003) Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology 61, 293-296.
5. Bhatnagar A., Sheffler D. J., Kroeze W. K., Compton-Toth B., and Roth B. L. (2004) Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J. Biol. Chem. 279, 34614-34623.
6. Bouvier M. (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2, 274-286.
7. Calon F., Dridi M., Hornykiewicz O., Bedard P. J., Rajput A. H., and Di Paolo T. (2004) Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain 127, 1075-1084.
8. Canals M., Marcellino M., Fanelli F., Ciruela F., de Benedetti P., Goldberg S., et al. (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization. Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 278, 46741-46749.
9. Ciruela F., Burgueno J., Casado V., Canals M., Marcellino D., Goldberg S. R., et al. (2004) Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal. Chem. 76, 5354-5363
10. Escriche M., Burgueno J., Ciruela F., Canela E. I., Mallol J., Enrich C., et al. (2003) Ligand-induced caveolae-mediated internalisation of A1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Exp. Cell. Res. 285, 72-90.
11. Ferré S. (1997) Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology 133, 107-120.
12. Ferré S., Ciruela F., Canals M., Marcellino D., Burgueno J., Casado V., et al. (2004) Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuropsychiatric disorders. Parkinsonism Relat. Disord. 10, 265-271.
13. Ferré S., Ciruela F., Woods A. S., Canals M., Burgueno J., Marcellino D., et al. (2003) Glutamate mGlu5-adenosine A2A-dopamine D2 receptor interactions in the striatum. Implications for drug therapy in neuropsychiatric disorders and drug abuse. Curr. Med. Chem. Central Nervous Systems Agents 33, 1-26.
14. Ferré S., Fredholm B. B., Morelli M., Popoli P., and Fuxe K. (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20, 482-487.
15. Ferré S., Fuxe K., von Euler G., Johansson B., and Fredholm B. B. (1992) Adenosine-dopamine interactions in the brain. Neuroscience 51, 501-512.
16. Ferré S., von Euler G., Johansson B., Fredholm B. B., and Fuxe K. (1991) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U. S. A. 88, 7238-7241.
17. Gainetdinov R. R., Premont R. T., Bohn L. M., Lefkowitz R. J., and Caron M. G. (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27, 107-144.
18. Guo W., Shi L., and Javitch J. A. (2003) The fourth transmembrane segment forms the interface of the dopamine D2 receptor homodimer. J. Biol. Chem. 278, 4385-4388.
19. Hauser R. A., Hubble J. P., and Truong D. D. (2003) Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Neurology 61, 297-303.
20. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., et al. (2002) Coaggregation, cointernalisation, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 277, 18091-18097.
21. Ishii M. and Kurachi Y. (2003) Physiological actions of regulators of G-protein signaling (RGS) proteins. Life Sci. 74, 163-171.
22. Kudlacek O., Just H., Korkhov V. M., Vartian N., Klinger M., Pankevych H., et al. (2003) The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Neuropsychopharmacology 28, 1317-1327.
23. Kull B., Ferré S., Arslan G., Svenningsson P., Fuxe K., Owman C., and Fredholm B. B. (1999) Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem. Pharmacol. 58, 1035-1045.
24. Kurzchalia T. V. and Parton R. G. (1999) Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11, 424-431.
25. Landmann L. (2002) Deconvolution improves colocalization analysis of multiple fluorochromes in 3D confocal data sets more than filtering techniques. J. Microsc. 208, 134-147.
26. Lee K. W., Hong J. H., Choi I. Y., Che Y., Lee J. K., Yang S. D., et al. (2002) Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22, 7931-7940.
27. Liu P., Rudick M., and Anderson R. G. (2002) Multiple functions of caveolin-1. J. Biol. Chem. 277, 41295-41298.
28. Manders E. M. M., Verbeek F. J., and Aten J. A. (1993) Measurement of co-localization of objects in dual-color confocal images. J. Microsc. 169, 375-382.
29. Miller W. E. and Lefkowitz R. J. (2001) Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr. Opin. Cell Biol. 13, 139-145.
30. Nabi I. R. and Le P. U. (2003) Caveolae/raft-dependent endocytosis. J. Cell Biol. 161, 673-677.
31. Nichols B. (2003) Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 116, 4707-4714.
32. Penela P., Ribas C., and Mayor F. Jr. (2003) Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell Signal. 15, 973-981.
33. Smart E. J., Graf G. A., McNiven M. A., Sessa W. C., Engelman J. A., Scherer P. E., et al. (1999) Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19, 7289-7304.
34. Tomiyama M., Kimura T., Maeda T., Tanaka H., Kannari K., and Baba M. (2004) Upregulation of striatal adenosine A2A receptor mRNA in 6-hydroxydopamine-lesioned rats intermittently treated with L-DOPA. Synapse 52, 218-222.
35. 2A receptor. J. Mol. Neurosci. 24, 273-280.
36. van Deurs B., Roepstorff K., Hommelgaard A. M., and Sandvig K. (2003) Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 13, 92-100.
37. Vortherms T. A. and Watts V. J. (2004) Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation. J. Pharmacol. Exp. Ther. 308, 221-227.
38. Webb R. H. and Dorey C. K. (1995) The pixilated image, in Handbook of Biological Confocal Microscopy, Pawley J. B., ed., Plenum Press, New York, pp. 55-67.
39. Yao L., Arolfo M. P., Dohrman D. P., Jiang Z., Fan P., Fuchs S., et al. (2002) betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell 109, 733-743.